Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771545012 | Velaglucerase alfa only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3771546013 | Product containing only velaglucerase alfa in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Velaglucerase alfa only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Velaglucerase alfa only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Velaglucerase alfa only product in parenteral dose form | Is a | Product containing velaglucerase alfa in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Velaglucerase alfa only product in parenteral dose form | Is a | Product containing only velaglucerase alfa (medicinal product) | true | Inferred relationship | Some | ||
| Velaglucerase alfa only product in parenteral dose form | Has active ingredient | Velaglucerase alfa (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | False | Velaglucerase alfa only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | False | Velaglucerase alfa only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | True | Velaglucerase alfa only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR